Bumper Offer - Urjas oil Just @ Rs. 1
Rcifax Suspension is a commercial drug that is prescribed in the form of Suspension. It is primarily used for the treatment of Hepatic Encephalopathy. Secondary and off-label uses of Rcifax Suspension have also been mentioned below.
The optimal dosage of Rcifax Suspension is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Rcifax Suspension include Flatulence, Bloating or fullness, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rcifax Suspension as well, which are listed below. These side effects of Rcifax Suspension are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Rcifax Suspension is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Rcifax Suspension related warnings talks about Rcifax Suspension's effects on the liver, heart and kidney.
The section on Rcifax Suspension contraindications lists all such conditions.
Drug reaction of Rcifax Suspension with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Rcifax Suspension is considered safe while driving, and is addictive.
Rcifax Suspension is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Rcifax Suspension is used -
Moderate
Mild
Common
Is the use of Rcifax Suspension safe for pregnant women?
Rcifax should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rcifax Suspension safe during breastfeeding?
Rcifax may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rcifax Suspension on the Kidneys?
There are no side effects of Rcifax on the kidneys.
What is the effect of Rcifax Suspension on the Liver?
Rcifax is rarely harmful for the liver.
What is the effect of Rcifax Suspension on the Heart?
There are no any side effects of Rcifax for the heart.
Rcifax Suspension should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rcifax Suspension unless your doctor advises you to do so -
Is this Rcifax Suspension habit forming or addictive?
Forming a habit of Rcifax Suspension has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rcifax Suspension since it will not make you feel sleepy.
Is it safe?
Yes, Rcifax Suspension is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Rcifax Suspension in mental disorders is not effective.
Interaction between Food and Rcifax Suspension
You can take Rcifax Suspension with food.
Interaction between Alcohol and Rcifax Suspension
No research has been done on this till date. Therefore, it is not known what the effect of taking Rcifax Suspension with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097